Prognostic impact of examined mediastinal lymph node count in clinical N0 non-small cell lung cancer.
Atsushi KamigaichiKeiju AokageShinya KatsumataGenichiro IshiiMasashi WakabayashiTomohiro MiyoshiKenta TaneJoji SamejimaMasahiro TsuboiPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Examining ≥3 mLNs contributed to a favourable prognosis and low mLN recurrence risk in patients with clinical stage I-II, N0 NSCLC. Our findings can serve as a benchmark for the number of required mLNs to be examined.